Lisa Giulino-Roth
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Year:
2026
The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13 , and PTPN1 , and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis. Significance: Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171
Year:
2025
The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13, and PTPN1, and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis. Significance: Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171
Year:
2023
Collaborators (22)
Raymond K H Yip
Walter and Eliza Hall Institute of Medical Research
Andriy Derkach
Associate Attending Biostatistician
Memorial Sloan Kettering Cancer Center
Olivier Elemento
Professor
Weill Cornell Medical College
Ola Landgren
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Siavash Foroughi
Walter and Eliza Hall Institute of Medical Research
james vince
Walter and Eliza Hall Institute of Medical Research
Alexandra Kovach
Director, Hematopathology; Associate Professor, Keck School of Medicine of University of Southern California
Children's Hospital of Los Angeles
Britt Christensen
-
Kelly L. Rogers
Laboratory Head, Dynamic Imaging & Centre Manager
Walter and Eliza Hall Institute of Medical Research
Bachisio Ziccheddu
Sylvester Comprehensive Cancer Center, University of Miami
Matthew Barth
Clinical Associate Professor
University at Buffalo State University of New York School of Medicine and Biomedical Sciences
Henning Walczak
Alexander-von-Humboldt Professor of Biochemistry
University of Cologne
Kate Lawlor
Group Leader
MONASH UNIVERSITY
Edwin Hawkins
Lab Head
Walter and Eliza Hall Institute of Medical Research
Rory Bowden
Lab Head
Walter and Eliza Hall Institute of Medical Research
Oliver Sieber
Laboratory Head
Walter and Eliza Hall Institute of Medical Research
Terzah Horton
Associate Professor
Baylor College of Medicine
Craig H. Moskowitz
University of Miami Miller School of Medicine
Pradeep Rajasekhar
MONASH UNIVERSITY
James Murphy
Laboratory Head
Walter and Eliza Hall Institute of Medical Research
Jinjin Chen
Walter and Eliza Hall Institute of Medical Research
Francesco Maura
Assistant Professor
Sylvester Comprehensive Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.